BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 30919030)

  • 1. Ketogenic diet ameliorates axonal defects and promotes myelination in Pelizaeus-Merzbacher disease.
    Stumpf SK; Berghoff SA; Trevisiol A; Spieth L; Düking T; Schneider LV; Schlaphoff L; Dreha-Kulaczewski S; Bley A; Burfeind D; Kusch K; Mitkovski M; Ruhwedel T; Guder P; Röhse H; Denecke J; Gärtner J; Möbius W; Nave KA; Saher G
    Acta Neuropathol; 2019 Jul; 138(1):147-161. PubMed ID: 30919030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of the Innate Immune Response by Human Neural Precursors Prevails over Oligodendrocyte Progenitor Remyelination to Rescue a Severe Model of Pelizaeus-Merzbacher Disease.
    Marteyn A; Sarrazin N; Yan J; Bachelin C; Deboux C; Santin MD; Gressens P; Zujovic V; Baron-Van Evercooren A
    Stem Cells; 2016 Apr; 34(4):984-96. PubMed ID: 26676415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapy of Pelizaeus-Merzbacher disease in mice by feeding a cholesterol-enriched diet.
    Saher G; Rudolphi F; Corthals K; Ruhwedel T; Schmidt KF; Löwel S; Dibaj P; Barrette B; Möbius W; Nave KA
    Nat Med; 2012 Jul; 18(7):1130-5. PubMed ID: 22706386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neural stem cells restore myelin in a demyelinating model of Pelizaeus-Merzbacher disease.
    Gruenenfelder FI; McLaughlin M; Griffiths IR; Garbern J; Thomson G; Kuzman P; Barrie JA; McCulloch ML; Penderis J; Stassart R; Nave KA; Edgar JM
    Brain; 2020 May; 143(5):1383-1399. PubMed ID: 32419025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modeling the Mutational and Phenotypic Landscapes of Pelizaeus-Merzbacher Disease with Human iPSC-Derived Oligodendrocytes.
    Nevin ZS; Factor DC; Karl RT; Douvaras P; Laukka J; Windrem MS; Goldman SA; Fossati V; Hobson GM; Tesar PJ
    Am J Hum Genet; 2017 Apr; 100(4):617-634. PubMed ID: 28366443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutation analysis of the M6b gene in patients with Pelizaeus-Merzbacher-like syndrome.
    Henneke M; Wehner LE; Hennies HC; Preuss N; Gärtner J
    Am J Med Genet A; 2004 Jul; 128A(2):156-8. PubMed ID: 15214007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of proteolipid protein rescues Pelizaeus-Merzbacher disease.
    Elitt MS; Barbar L; Shick HE; Powers BE; Maeno-Hikichi Y; Madhavan M; Allan KC; Nawash BS; Gevorgyan AS; Hung S; Nevin ZS; Olsen HE; Hitomi M; Schlatzer DM; Zhao HT; Swayze A; LePage DF; Jiang W; Conlon RA; Rigo F; Tesar PJ
    Nature; 2020 Sep; 585(7825):397-403. PubMed ID: 32610343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurogenetics of Pelizaeus-Merzbacher disease.
    Osório MJ; Goldman SA
    Handb Clin Neurol; 2018; 148():701-722. PubMed ID: 29478609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pelizaeus-Merzbacher disease: on the cusp of myelin medicine.
    Elitt MS; Tesar PJ
    Trends Mol Med; 2024 May; 30(5):459-470. PubMed ID: 38582621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oligodendrocyte Death in Pelizaeus-Merzbacher Disease Is Rescued by Iron Chelation.
    Nobuta H; Yang N; Ng YH; Marro SG; Sabeur K; Chavali M; Stockley JH; Killilea DW; Walter PB; Zhao C; Huie P; Goldman SA; Kriegstein AR; Franklin RJM; Rowitch DH; Wernig M
    Cell Stem Cell; 2019 Oct; 25(4):531-541.e6. PubMed ID: 31585094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemical Screening Identifies Enhancers of Mutant Oligodendrocyte Survival and Unmasks a Distinct Pathological Phase in Pelizaeus-Merzbacher Disease.
    Elitt MS; Shick HE; Madhavan M; Allan KC; Clayton BLL; Weng C; Miller TE; Factor DC; Barbar L; Nawash BS; Nevin ZS; Lager AM; Li Y; Jin F; Adams DJ; Tesar PJ
    Stem Cell Reports; 2018 Sep; 11(3):711-726. PubMed ID: 30146490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gait abnormalities and progressive myelin degeneration in a new murine model of Pelizaeus-Merzbacher disease with tandem genomic duplication.
    Clark K; Sakowski L; Sperle K; Banser L; Landel CP; Bessert DA; Skoff RP; Hobson GM
    J Neurosci; 2013 Jul; 33(29):11788-99. PubMed ID: 23864668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Demyelination and axonal preservation in a transgenic mouse model of Pelizaeus-Merzbacher disease.
    Edgar JM; McCulloch MC; Montague P; Brown AM; Thilemann S; Pratola L; Gruenenfelder FI; Griffiths IR; Nave KA
    EMBO Mol Med; 2010 Feb; 2(2):42-50. PubMed ID: 20091761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling the natural history of Pelizaeus-Merzbacher disease.
    Mayer JA; Griffiths IR; Goldman JE; Smith CM; Cooksey E; Radcliff AB; Duncan ID
    Neurobiol Dis; 2015 Mar; 75():115-30. PubMed ID: 25562656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of kinase-deficient MEK2 ameliorates Pelizaeus-Merzbacher disease phenotypes in mice.
    Miyamoto Y; Tanaka M; Ito H; Ooizumi H; Ohbuchi K; Mizoguchi K; Torii T; Yamauchi J
    Biochem Biophys Res Commun; 2020 Oct; 531(4):445-451. PubMed ID: 32800341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of curcumin in a mouse model of Pelizaeus-Merzbacher disease.
    Yu LH; Morimura T; Numata Y; Yamamoto R; Inoue N; Antalfy B; Goto Y; Deguchi K; Osaka H; Inoue K
    Mol Genet Metab; 2012 May; 106(1):108-14. PubMed ID: 22436581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is involvement of inflammation underestimated in Pelizaeus-Merzbacher disease?
    Marteyn A; Baron-Van Evercooren A
    J Neurosci Res; 2016 Dec; 94(12):1572-1578. PubMed ID: 27661457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of ER stress in dysmyelination of Pelizaeus-Merzbacher Disease with PLP1 missense mutations shown by iPSC-derived oligodendrocytes.
    Numasawa-Kuroiwa Y; Okada Y; Shibata S; Kishi N; Akamatsu W; Shoji M; Nakanishi A; Oyama M; Osaka H; Inoue K; Takahashi K; Yamanaka S; Kosaki K; Takahashi T; Okano H
    Stem Cell Reports; 2014 May; 2(5):648-61. PubMed ID: 24936452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene suppressing therapy for Pelizaeus-Merzbacher disease using artificial microRNA.
    Li H; Okada H; Suzuki S; Sakai K; Izumi H; Matsushima Y; Ichinohe N; Goto YI; Okada T; Inoue K
    JCI Insight; 2019 May; 4(10):. PubMed ID: 31092737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A common mechanism of PLP/DM20 misfolding causes cysteine-mediated endoplasmic reticulum retention in oligodendrocytes and Pelizaeus-Merzbacher disease.
    Dhaunchak AS; Nave KA
    Proc Natl Acad Sci U S A; 2007 Nov; 104(45):17813-8. PubMed ID: 17962415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.